Compositions and their uses directed to acetyl-CoA carboxylases

NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF

Prostate cancer related gene STYK1

RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma

MAT II β subunit RNAi and therapeutic methods using same

METHOD OF PROMOTING NEUROGENESIS BY MODULATING SECRETASE ACTIVITIES

Antiviral Oligonucleotides Having a Conserved G4 Core Sequence

RNAI-MEDIATED INHIBITION OF OCULAR HYPERTENSION TARGETS

Diagnosis and Treatment of Malignant Neoplasms

Methods and compositions for vitamin K epoxide reductase

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

Interfering RNA molecules

Use on minicircle vectors for cardiac gene therapy

USES OF CALPAIN INHIBITORS TO INHIBIT INFLAMMATION

ADAM-15 antibodies and immunogenic peptides

Compositions and methods for inhibiting expression of IKK-B gene

Compositions and their uses directed to PTPRU

RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA

siRNA targeting spleen tyrosine kinase

RNA interference suppresion of neurodegenerative diseases and methods of use thereof

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

Means and methods for counteracting, delaying and/or preventing heart disease

siRNA targeting TNFa

Methods and Compositions for Treating Polyps

SIRT4 ACTIVITIES

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

Methods and compositions for increasing the activity of inhibitory RNA

MODULATION OF MLCK-L EXPRESSION AND USES THEREOF

Cochleate compositions directed against expression of proteins

Reduction of -phosphatidylcholine acyltransferase activity

OLIGONUCLEOTIDES AFFECTING EXPRESSION OF PHOSPHODIESTERASES

DELIVERY OF siRNAs

Oligonucleotide compositions and methods for treating disease including inflammatory conditions

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Means and Methods for Influencing Electrical Activity of Cells

RNA antagonist compounds for the modulation of PIK3CA expression

Lipid formulations for nucleic acid delivery

THERAPEUTIC METHODS AND COMPOSITIONS

Detection of mutations in a gene associated with resistance to viral infection, OAS1

Methods of treating B-cell cancers

Compounds and methods for modulating expression of SGLT2

COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USE

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

COMBINATION THERAPY

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Chd5 is a novel tumor suppressor gene

Therapeutic compositions

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders

Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

LIVER SCREENING METHOD

Transfection results of non-viral gene delivery systems by influencing of the innate immune system

Modified RNAi polynucleotides and uses thereof

Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis

INHIBITORY POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING CANCER

Induction of thyroid iodide-handling gene expression in human cancers

Compositions and methods for inhibiting expression of CD45 gene

Positive controls for expression modulating experiments

Method for increasing bone mass

Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them

METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION

NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Sugar Chain-Related Gene and Use Thereof

Methods for nucleic acid transfer into cells

Lipid formulated dsRNA targeting the PCSK9 gene

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE

METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND OTHER ANGIOGENESIS-RELATED DISEASES

PTTG1 as a biomarker for cancer treatment

Compositions and methods for controlled delivery of inhibitory ribonucleic acids

Further Use of Protein Kinase N Beta

Treating oncogenic Ras driven cancers

ALLOSTERIC TRANS-SPLICING GROUP I RIBOZYME WHOSE ACTIVITY OF TARGET-SPECIFIC RNA REPLACEMENT IS CONTROLLED BY THEOPHYLLINE

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

Compositions and methods for inhibiting optic nerve damage

Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof

ANTIBODIES WITH ENHANCED ADCC FUNCTION

Methods of inhibiting tumor growth using TTK antagonists

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers

ZAP-70 as predictor and modulator of effector function of T cells

Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides

Aminoalcohol lipidoids and uses thereof

siRNA Targeting Survivin

Compositions and methods for identification of PARP function, inhibitors, and activators

PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS

Lipid formulation

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

GDE Compositions and Methods

TP expression-inhibiting compound and siRNA sequence thereof

Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

Modulation of diacylglycerol acyltransferase 2 expression

METHODS FOR IDENTIFYING DIABETES AND OBESITY THERAPEUTICS

ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A)

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

GENES AND POLYMORPHISMS ASSOCIATED WITH AMD

Modulation of factor 7 expression

Oligonucleotide Compositions with Enhanced Efficiency

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

CANCER BIOMARKER AND USES THEREOF

INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION THROUGH MODULATION OF CARNITINE PALMITOYLTRANSFERASE 1C ACTIVITY

Methods and compositions for selecting siRNA of improved functionality

Compositions and methods for improved glycoprotein sialylation

COMPOSITIONS AND METHODS FOR INHIBITING INDUCIBLE T CELL KINASE (ITK) AND TREATING ASTHMA AND BRONCHIAL INFLAMMATIONS

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK

Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy

Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulation

Animal models for demyelination disorders

DOUBLE-STRANDED RIBONUCLEIC ACID WITH INCREASED EFFECTIVENESS IN AN ORGANISM

COMPOSITIONS COMPRISING HUMAN INTEGRIN-LINKED KINASE-SIRNA AND METHODS OF USE THEREOF

Lepidopteran insect N-acetylglucosaminidase genes and their use in glycoengineering

Compositions And Methods For Reducing Cancer And Inflammation

Mycobacterial peptide deformylase

COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION

JNK3 as a target for the treatment of angiogenesis-related diseases

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

siRNA targeting KRAS

Laccases, nucleic acids encoding them and methods for making and using them

Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases

Breast Cancer Methods, Medicaments and Agents

BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET

Method for increasing immunoreactivity

SHIP-deficiency to increase megakaryocyte progenitor production

ANTIVIRAL INHIBITION OF CASEIN KINASE II

Use of protease nexin 1 inhibitors to reduce metastasis

Modulators of pharmacological agents

MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES

DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS

siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)

Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same

Therapeutic compositions

Antisense modulation of kinesin-like 1 expression

EML4-ALK fusion gene

Methods of treatment of skin ulcers

LNA antagonists targeting the androgen receptor

Method of Treating Pain by Using Opioids and CAMKIV Inhibitors

siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof

VHZ for diagnosis and treatment of cancer

High potency siRNAS for reducing the expression of target genes

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

RNA Antagonist Compounds for the Modulation of PCSK9

Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis

VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS

Chemotherapeutic methods and compositions

NEW MODALITIES FOR TREATMENT OF DRUG-RESISTANT TUBERCULOSIS AND OTHER DISEASES

OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Use of antisense oligonucleotides against CPLA2 in the treatment of cancer

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES

Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer

ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

Application of RNA Interference Targeting dhfr Gene, to Cell for Producing Secretory Protein

Modulation of blood brain barrier protein expression

5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom

Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity

siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS

CELL-BASED RNA INTERFERENCE AND RELATED METHODS AND COMPOSITIONS

Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

dsRNA For Treating Viral Infection

BGL6 β-glucosidase and nucleic acids encoding the same

SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX

dsRNA FOR TREATING VIRAL INFECTION

METHODS OF USING MEVALONATE DECARBOXYLASE (MVD) ANTAGONISTS

PREVENTIVE/REMEDY FOR CANCER

DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

Apoptosis inducer for cancer cell

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

RAD 9 AS A DIAGNOSTIC,PROGNOSTIC,AND THERAPEUTIC TOOL FOR PROSTATE CANCER

Methods and Compositions for Treating Cancer

RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS

Methods and compositions concerning siRNA's as mediators of RNA interference

Production of reprogrammed cells with restored potential

Antibody that specifically binds hyaluronan synthase

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

siRNA targeting BCL2L1

Methods and Systems for Searching for Regulators of the Fer Protein and for Monitoring the Effects of the Fer Protein

siRNA targeting nucleoporin 62kDa (Nup62)

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

Methods for treating hypercholesterolemia

Methods involving aldose reductase inhibitors

Alpha-synuclein kinase

Development of asthma therapy with rAAV-mediated AMCase shRNA

Complement inhibition for improved nerve regeneration

Modulation of factor 11 expression

Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation

ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

DOUBLE-STRANDED OLIGONUCLEOTIDES

Polyvalent RNA-nanoparticle compositions

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis

Methods for treating and preventing multiple sclerosis

Methods of modulating angiogenesis

Methods and materials for determining pain sensitivity and predicting and treating related disorders

Lipid formulations for nucleic acid delivery

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES

Polypeptides having feruloyl esterase activity and polynucleotides encoding same

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

Method for Treating Pain with a Calmodulin Inhibitor

Methods for treating hematopoietic malignancies

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

RNAi mediated expression inhibition of a cholinergic protein

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

Compositions and methods for gene silencing

COMPOSITIONS AND METHODS FOR TREATING MYELOSUPPRESSION

Wound healing

Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts

Modulation of MLCK-L expression and uses thereof

Diagnosis and treatment of malignant neoplasms

Modification of exosomal components for use as a vaccine

MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE

siRNA targeting spleen tyrosine kinase

METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION

Isoform of bruton's tyrosine kinase (BTK) protein

Genetic transformation of algal and cyanobacteria cells by microporation

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES

METHOD OF TREATMENT AND PROPHYLAXIS

COMPOSITIONS AND METHODS FOR MODULATION OF SUPPRESSOR T CELL ACTIVATION

Transgenic sweet sorghum with altered lignin composition and process of preparation thereof

Methods of eliminating or reducing expression of genes in filamentous fungal strains by transitive RNA interference

INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS

Oligonucleotides affecting expression of phosphodiesterases

INHIBITION OF THE 44 KILODALTON ISOFORM OF PIM-1 KINASE RESTORES APOPTOSIS INDUCED BY CHEMOTHERAPEUTIC DRUGS IN CANCER CELLS

INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

Activation and transfer cascade for ubiquitin

Methods and Compositions for Treating Vascular Disease

Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents

Gene vector

EFFICIENT REDUCTION OF TARGET RNA'S BY SINGLE- AND DOUBLE-STRANDED OLIGOMERIC COMPOUNDS

Methods and compositions for reducing amyloid beta levels

SIRNA inhibition of PI3K P85, P110, and AKT2 and methods of use

Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease

Composition and method for treatment of tumors

siRNA targeting survivin

SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA 1,6-FUCOSYLTRANSFERASE

Compositions and Methods to Treat Bone Related Disorders

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

Combined telomerase inhibitor and gemcitabine for the treatment of cancer

Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity

METHOD FOR CONSTRUCTING MICRORNA ADENOVIRUS EXPRESSION PLASMIDS OF SEVERE HEPATITIS RELATED HFGL2, HFAS AND HTNFR1 GENES AND PHARMACEUTICAL USE THEREOF

SELECTION METHOD

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

Cancer treatment by combined inhibition of proteasome and telomerase activities

COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID

Compositions and Methods of Using RNA Interference of SCA1-Like Genes for Control of Nematodes

siRNA targeting myeloid cell Leukemia sequence 1

Multivalent rna nanoparticles for delivery of active agents to a cell

Polypeptides having endoglucanase activity and polynucleotides encoding same

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

RNAi-Mediated Inhibition of Ocular Targets

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2

ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

Oligonucleotides comprising a non-phosphate backbone linkage

Methods for treating hypercholesterolemia

β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis

Compounds and methods for modulating expression of PTP1B

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES SPECIFIC TO GLOBO H AND SSEA3 AND USES THEREOF IN CANCER TREATMENT

Methods to predict and prevent resistance to taxoid compounds

Protection against and treatment of age related macular degeneration

Screening method

Materials and methods directed to asparagine synthetase and asparaginase therapies

Compounds and methods for modulating expression of GCCR

siRNA targeting TNFα

Modulators of Itch ubiquitinase activity

Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulation

RNA INTERFERENCE MEDIATED INHIBITION OF MAP KINASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Compounds and methods for modulating expression ApoB

Compounds and methods for modulating expression of GCGR

Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification

Compounds and methods for modulating expression of PCSK9

Means for inhibiting the expression of protein kinase 3

SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES

Arginase II: A Target treatment of aging heart and heart failure

siRNA targeting KRAS

Use of Caspase-8 Inhibitors for Modulating Hematopoiesis

ADAM10 in Cancer Diagnosis, Detection and Treatment

GENES FOR MICROSOMAL DELTA-12 FATTY ACID DESATURASES AND RELATED ENZYMES FROM PLANTS

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2

siRNA targeting transducin (beta)-like 3 (TBL3)

Silencing of polo-like kinase expression using interfering RNA

Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION